文献速递生殖医学

基于延时监测的非侵入性胚胎评估与选择对比传统形态学评估在体外受精/卵胞浆内单精子注射女性中的随机对照研究

Noninvasive embryo evaluation and selection by time-lapse monitoring vs. conventional morphologic assessment in women undergoing in vitro fertilization/intracytoplasmic sperm injection: a single-center randomized controlled study.
PubMed 文献 · Fertil Steril · 2022-03-30

该单中心前瞻性随机对照试验将139名首次接受体外受精或卵胞浆内单精子注射的女性随机分为延时监测(TLM)组和传统形态学评估(CMA)组,每组仅移植1枚卵裂期胚胎。结果显示TLM组临床妊娠率和活产率均显著低于CMA组,作者认为在年轻且卵巢储备良好的女性中,TLM选择卵裂期胚胎并无优势,仍属研究性操作。

要点

  • TLM组临床妊娠率49.18%显著低于CMA组70.42%(RR 0.70,95%CI 0.52-0.94)。
  • TLM组活产率45.90%显著低于CMA组64.79%(RR 0.71,95%CI 0.51-0.98)。
  • 作者结论认为TLM仍是体外受精实践中的研究性操作。

核心结论

  • 在年轻且卵巢储备良好的女性中,基于TLM选择的择期单卵裂期胚胎移植相比CMA(结合第2天和第3天胚胎形态)并无任何优势。
  • 作者据此认为TLM仍是体外受精实践中的研究性操作。

研究设计与样本

  • 前瞻性随机对照试验,单学术中心开展。
  • 139名首次接受体外受精或卵胞浆内单精子注射的女性被随机分配至新鲜胚胎移植或首次冻融胚胎移植,每名参与者仅移植1枚卵裂期胚胎。
  • 患者随机分为CMA组和TLM组,CMA组观察第2天和第3天胚胎,两组均选择优质卵裂期胚胎用于移植或冷冻。
  • 主要结局为首次胚胎移植(新鲜胚胎移植或冻融胚胎移植)后的临床妊娠率,次要结局为活产率。
  • 临床试验注册号:ChiCTR1900021981。

主要发现

  • TLM组临床妊娠率49.18% vs CMA组70.42%(相对风险0.70,95%CI 0.52-0.94),TLM组显著低于CMA组。
  • TLM组活产率45.90% vs CMA组64.79%(相对风险0.71,95%CI 0.51-0.98),TLM组显著低于CMA组。
  • 新鲜胚胎移植后临床妊娠率TLM组44.44% vs CMA组70.0%(相对风险0.63,95%CI 0.39-1.03),两组无显著差异。
  • 冻融胚胎移植后临床妊娠率TLM组52.94% vs CMA组70.73%(相对风险0.75,95%CI 0.52-1.09),两组无显著差异。
  • 新鲜胚胎移植后活产率TLM组40.74% vs CMA组66.67%(相对风险0.61,95%CI 0.36-1.03),两组差异未达统计学显著;冻融胚胎移植后活产率TLM组50.0% vs CMA组63.41%(相对风险0.79,95%CI 0.52-1.19),两组相似。

临床怎么用

  • 作者结论认为,在年轻且卵巢储备良好的女性中,基于TLM选择的择期单卵裂期胚胎移植相比CMA无优势。
  • 作者认为TLM仍是体外受精实践中的研究性操作。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine whether time-lapse monitoring (TLM) for cleavage-stage embryo selection improves reproductive outcomes in comparison with conventional morphological assessment (CMA) selection. DESIGN: Prospective randomized controlled trial. SETTING: Single academic center. PATIENTS: We randomly assigned 139 women who were undergoing their first in vitro fertilization or intracytoplasmic sperm injection cycle to undergo either fresh embryo transfer or first frozen embryo transfer (FET). Only 1 cleavage-stage embryo was transferred to each participant. INTERVENTIONS: The patients were randomly assigned to either the CMA or the TLM group. In the CMA group, day 2 and day 3 embryos were observed. A good-quality cleavage-stage embryo was selected for transfer or freezing in both groups. MAIN OUTCOME MEASURES: The primary and secondary outcomes were the clinical pregnancy rate (CPR) and the live birth rate (LBR), respectively, after the first embryo transfer (fresh embryo transfer or FET). RESULTS: The CPR and LBR were significantly lower in the TLM group than in the CMA group (CPR: 49.18% vs. 70.42%; relative risk, 0.70; 95% confidence interval [CI], 0.52-0.94; LBR: 45.90% vs. 64.79%; relative risk, 0.71; 95% CI, 0.51-0.98). The CPR with fresh embryo transfer or FET did not significantly differ between the TLM and the CMA groups (fresh embryo transfer: 44.44% vs. 70.0%, relative risk, 0.63, 95% CI, 0.39-1.03; FET: 52.94% vs. 70.73%, relative risk, 0.75, 95% CI, 0.52-1.09). There was a significant difference in the LBR with fresh embryo transfer between the TLM and the CMA groups (40.74% vs. 66.67%; relative risk, 0.61; 95% CI, 0.36-1.03). The LBRs with FET were similar in the TLM and the CMA groups (50.0% vs. 63.41%; relative risk, 0.79; 95% CI, 0.52-1.19). The rates of early spontaneous abortion and ectopic pregnancy did not differ between the TLM and the CMA groups. CONCLUSIONS: Elective single cleavage-stage embryo transfer with TLM-based selection did not have any advantages over CMA when day 2 and day 3 embryo morphology was combined in young women with a good ovarian reserve. Because of these results, we conclude that TLM remains an investigational procedure for in vitro fertilization practice. CLINICAL TRIAL REGISTRATION NUMBER: ChiCTR1900021981.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Meng Q, Xu Y, Zheng A, et al. Noninvasive embryo evaluation and selection by time-lapse monitoring vs. conventional morphologic assessment in women undergoing in vitro fertilization/intracytoplasmic sperm injection: a single-center randomized controlled study. Fertil Steril. 2022. PMID: 35367059. doi:10.1016/j.fertnstert.2022.02.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。